Table 1.
EDRN Cohort Subject and Disease Characteristics
All Cases | TMA Cases | RPPA Cases | QPCR Cases | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n=154 | n=58 | P* | n=67 | P* | n=50 | P* | |||||
Gender | |||||||||||
Male | 110 | 71.4% | 41 | 70.7% | 0.88‡ | 48 | 71.6% | 0.96‡ | 36 | 72.0% | 0.91‡ |
Female | 44 | 28.6% | 17 | 29.3% | 19 | 28.4% | 14 | 28.0% | |||
Ethnicity | |||||||||||
White | 148 | 96.1% | 57 | 98.3% | 0.41∥ | 65 | 97.0% | 0.69∥ | 51 | 98.1% | 0.66∥ |
Non-white | 6 | 4.4% | 1 | 4.4% | 2 | 4.4% | 1 | 4.4% | |||
Age, years | |||||||||||
Median (Range) | 58 (23–89) | 61 (23–80) | 0.42§ | 58 (23–80) | 0.76§ | 60 (23–80) | 0.44§ | ||||
Smoking Status | |||||||||||
Never smoker | 24 | 15.6% | 6 | 10.3% | 0.20‡ | 9 | 13.4% | 0.79‡ | 6 | 12.0% | 0.65‡ |
Former smoker | 50 | 32.5% | 23 | 39.7% | 23 | 34.3% | 16 | 32.0% | |||
Active Smoker | 80 | 51.9% | 29 | 50.0% | 35 | 52.2% | 28 | 56.0% | |||
Cigarette Pack-Years | |||||||||||
Never smoker | 24 | 15.6% | 6 | 10.3% | 0.16‡ | 9 | 13.4% | 0.42‡ | 6 | 12.0% | 0.45‡ |
1–59 py | 57 | 37.0% | 18 | 31.0% | 21 | 31.3% | 17 | 34.0% | |||
≥60 py | 58 | 37.7% | 26 | 44.8% | 28 | 41.8% | 22 | 44.0% | |||
Unknown | 15 | 9.7% | 8 | 13.8% | 9 | 13.4% | 5 | 10.0% | |||
Alcohol Drinker | |||||||||||
Never drinker | 40 | 26.0% | 16 | 27.6% | 0.72‡ | 18 | 26.9% | 0.82‡ | 14 | 28.0% | 0.69‡ |
Ever drinker | 114 | 74.8% | 42 | 74.8% | 49 | 74.8% | 36 | 74.8% | |||
Alcohol Quantity† | |||||||||||
Never drinker | 40 | 26.0% | 16 | 27.6% | 0.85‡ | 18 | 26.9% | 0.43‡ | 14 | 28.0% | 0.08‡ |
1–4 | 48 | 31.2% | 16 | 27.6% | 18 | 26.9% | 9 | 18.0% | |||
≥5 | 46 | 29.9% | 19 | 32.8% | 24 | 35.8% | 20 | 40.0% | |||
Unknown | 20 | 13.0% | 7 | 12.1% | 7 | 10.4% | 7 | 14.0% | |||
Tumor Type | |||||||||||
Neck Metastasis | 2 | 1.3% | 2 | 3.4% | .15∥ | 2 | 3.0% | .30∥ | 1 | 2.0% | .28∥ |
New Primary | 11 | 7.1% | 2 | 3.4% | 3 | 4.5% | 1 | 2.0% | |||
Primary | 128 | 83.1% | 50 | 86.2% | 57 | 85.1% | 43 | 86.0% | |||
Recurrence | 13 | 8.4% | 4 | 6.9% | 5 | 7.5% | 5 | 10.0% | |||
Tumor Site | |||||||||||
Oral Cavity | 70 | 45.5% | 23 | 39.7% | .32∥ | 27 | 40.3% | .23∥ | 16 | 32.0% | .06∥ |
Oropharynx | 29 | 18.8% | 12 | 20.7% | 12 | 17.9% | 12 | 24.0% | |||
Hypopharynx | 11 | 7.1% | 2 | 3.4% | 3 | 4.5% | 2 | 4.0% | |||
Larynx | 40 | 26.0% | 19 | 32.8% | 22 | 32.8% | 18 | 36.0% | |||
Neck | 4 | 2.6% | 2 | 3.4% | 3 | 4.5% | 2 | 4.0% | |||
Disease Stage | |||||||||||
I | 26 | 16.9% | 6 | 10.3% | .09∥ | 6 | 9.0% | .049∥ | 5 | 10.0% | .45∥ |
II | 21 | 13.6% | 11 | 19.0% | 13 | 19.4% | 7 | 14.0% | |||
III | 30 | 19.5% | 7 | 12.1% | 10 | 14.9% | 8 | 16.0% | |||
IV | 61 | 39.6% | 27 | 46.6% | 30 | 44.8% | 23 | 46.0% | |||
Recurrence/Metastasis | 15 | 9.7% | 6 | 10.3% | 7 | 10.4% | 6 | 12.0% | |||
Unknown | 1 | 0.6% | 1 | 1.7% | 1 | 1.5% | 1 | 2.0% | |||
Treatment | |||||||||||
RT Only | 41 | 26.8% | 19 | 32.8% | .43∥ | 20 | 29.0% | .73∥ | 18 | 36.0% | .16∥ |
CRT | 27 | 17.6% | 10 | 17.2% | 11 | 15.9% | 9 | 18.0% | |||
No CRT | 79 | 51.6% | 27 | 46.6% | 35 | 50.7% | 21 | 42.0% | |||
Unknown | 6 | 3.9% | 2 | 3.4% | 3 | 4.3% | 2 | 4.0% | |||
Vital Status | |||||||||||
Alive | 79 | 51.3% | 26 | 44.8% | 0.15‡ | 30 | 44.8% | 0.12‡ | 20 | 40.0% | 0.04‡ |
Dead | 73 | 47.4% | 32 | 55.2% | 37 | 55.2% | 30 | 60.0% | |||
Unknown | 2 | 1.3% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | |||
Time to Death, months | |||||||||||
Median (Range) | 44.6 (1.5–112.3) | 42.2 (1.5–112.3) | 0.44¶ | 42.5 (1.5–112.3) | 0.21¶ | 44.2 (1.5–112.3) | 0.21¶ | ||||
Disease Progression Status | |||||||||||
No disease progression | 64 | 41.6% | 22 | 37.9% | 26 | 38.8% | 16 | 32.0% | |||
0.41‡ | 0.46‡ | 0.08‡ | |||||||||
Disease Progression | 88 | 57.1% | 36 | 62.1% | 41 | 61.2% | 34 | 68.0% | |||
Unknown | 2 | 1.3% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | |||
Progression Free Survival, months | |||||||||||
Median (Range) | 33.8 (1.2–108.4) | 26.4 (1.2–106.9) | 0.51¶ | 26.8 (1.2–106.9) | 0.40¶ | 24.8 (1.2–106.9) | 0.28¶ |
Typical number of alcohol drinks in 2 week period
Chi square test
Rank sum test
Fisher's exact test
Log rank test
Analyzed versus unanalyzed cases